Market News AIOpen the app

Microbot Medical Inc. filed its Q3 2026 report, showing lower revenue but more use of its LIBERTY robot system.

ResultsRead the original at SEC EDGAR
Neutral

Microbot's sales fell and its gross margin was negative, but procedures rose 44% and customer accounts grew from 10 to 12. The report shows weaker sales alongside wider use, so it does not point clearly one way.

MBOT · Microbot Medical Inc.

AI read · Neutral

The AI's read

More procedures, repeat orders, and new hospital accounts suggest growing use of LIBERTY. A 3-year exclusive Israel sales agreement adds another way to reach customers. But sales fell, and the company reported a negative gross margin. It also had about $62 million in cash, and its production costs per unit kept falling. These facts point in different directions, so the report does not clearly change how we read the company.

Get alerts for MBOT

Follow Microbot Medical Inc. (MBOT) free. When we publish a story about it, you get the plain-English explanation as an alert.

Get alerts for MBOT
Free on the App Store and Google Play, or on the web.